Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events
Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. Patients and method...
Saved in:
Published in | BMC cancer Vol. 21; no. 1; pp. 1 - 11 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central Ltd
27.07.2021
BioMed Central BMC |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. Patients and methods A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson's correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach's É, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). Results Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach's É of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71-0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. Conclusion The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. Keywords: Patient-reported outcomes, PRO-CTCAE, Chinese, Validity, Reliability |
---|---|
AbstractList | The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness.BACKGROUNDThe psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness.A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson's correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach's ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs).PATIENTS AND METHODSA Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson's correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach's ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs).Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach's ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71-0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness.RESULTSData from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach's ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71-0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness.The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness.CONCLUSIONThe simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson's correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach's É, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach's É of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71-0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. Abstract Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. Patients and methods A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson’s correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach’s ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). Results Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach’s ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71–0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. Conclusion The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. Patients and methods A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson's correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach's É, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). Results Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach's É of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71-0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. Conclusion The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. Keywords: Patient-reported outcomes, PRO-CTCAE, Chinese, Validity, Reliability Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) have not been assessed. Therefore, we aimed to assess its validity, reliability, and responsiveness. Patients and methods A Chinese version of the PRO-CTCAE and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (QLQ-C30) were distributed to 1580 patients from four cancer hospitals in China. Validity assessments included construct validity, measured by Pearson’s correlations and confirmatory factor analysis (CFA), and known-groups validity, measured by t-tests. The assessment of reliability included internal consistency, measured by Cronbach’s ɑ, and test-retest reliability, measured by the intraclass correlation (ICC). Responsiveness was assessed by standardized response means (SRMs). Results Data from 1555 patients who completed the instruments were analyzed. The correlations were high between PRO-CTCAE items and parallel QLQ-C30 symptom scales (r > 0.60, p < 0.001), except for fatigue (severity: r = 0.49). Moreover, CFA showed the PRO-CTCAE structure was a good fit with the data (Root Mean Square Error of Approximation = 0.046). Known-groups validity was also confirmed. Cronbach’s ɑ of all item clusters were greater than 0.9 and the median test-retest reliability coefficients of the 38 items were 0.85 (range = 0.71–0.91). In addition, the SRMs of PRO-CTCAE items were greater than 0.8, indicating strong responsiveness. Conclusion The simplified Chinese version of the PRO-CTCAE showed good reliability, validity, and responsiveness. |
ArticleNumber | 860 |
Audience | Academic |
Author | Sun, Ying Huang, Bo-Jie Mao, Yan-Ping Liu, Ying Xie, Fang-Yun Chen, Lei Yang, Shan-Shan Ma, Jun Lu, Hai-Jun Lin, Ai-Hua |
Author_xml | – sequence: 1 givenname: Shan-Shan surname: Yang fullname: Yang, Shan-Shan – sequence: 2 givenname: Lei surname: Chen fullname: Chen, Lei – sequence: 3 givenname: Ying surname: Liu fullname: Liu, Ying – sequence: 4 givenname: Hai-Jun surname: Lu fullname: Lu, Hai-Jun – sequence: 5 givenname: Bo-Jie surname: Huang fullname: Huang, Bo-Jie – sequence: 6 givenname: Ai-Hua surname: Lin fullname: Lin, Ai-Hua – sequence: 7 givenname: Ying surname: Sun fullname: Sun, Ying – sequence: 8 givenname: Jun surname: Ma fullname: Ma, Jun – sequence: 9 givenname: Fang-Yun surname: Xie fullname: Xie, Fang-Yun – sequence: 10 givenname: Yan-Ping surname: Mao fullname: Mao, Yan-Ping |
BookMark | eNp9ktlq3DAUhk1JaZb2BXplKJT0wqk2y5qbQhi6BAKFbrfiWD6aUZCtqSSH5hX61NVkEpoJpehCOkff_2vhP64OpjBhVb2k5IxSJd8mypRqG8JoQ5SkpCFPqiMqOtowQbqDB-vD6jilK0Jop4h6Vh1ywWkrGD-qfv8A7waXb2qYhjqid9A7v62DrfMa6-TGjXfW4VAv127ChPUGssMpNxE3IeayEeZswoipvsaYXJjutaU5lipjHN0UfFjd1Ca6UjqobYg1DFsB1nhd7NLz6qkFn_DF3XxSff_w_tvyU3P5-ePF8vyyMZK0uZFgwSCxqETHekkk72zfo2GCW9UyIACokAjT95YDH7oOpVSAjHKlGAh-Ul3sfIcAV3oT3QjxRgdw-rYR4kpDzM541As-EGkoo2YwAnnfC9ZxCQtshWStHYrXu53XZu5HHEx5RwS_Z7q_M7m1XoVrrTgVrWLF4PTOIIafM6asR5cMeg8Thjlp1rbtQnYdaQv66hF6FeY4la8qVLlOJzld_KVWUB7gJhvKuWZrqs9lx7hQcrGlzv5BlTHg6EyJmXWlvyd4sycoTMZfeQVzSvri65d99vUDdo3g8zoFP-cSjbQPqh1oYkgpotXGZdhi5TbOa0r0Nuh6F3Rdgq5vg65JkbJH0vs__4_oD2JtAgA |
CitedBy_id | crossref_primary_10_1186_s12957_022_02679_y crossref_primary_10_1016_j_ijrobp_2022_11_036 |
Cites_doi | 10.1093/jnci/dju244 10.1080/10705519909540118 10.1007/s11136-013-0470-1 10.1093/jnci/dju129 10.1093/annonc/mdp542 10.1200/JCO.2014.57.9334 10.1016/j.jpainsymman.2020.01.015 10.1001/jamaoncol.2015.2639 10.1007/s00520-017-3764-y 10.1016/j.jpainsymman.2013.10.027 10.1056/NEJMp0911494 10.1016/j.jad.2020.04.060 10.1186/s12885-020-07631-5 10.1016/j.jval.2011.06.003 10.1186/s41687-017-0022-5 10.1093/jnci/85.5.365 10.1177/002224378101800104 10.1093/annonc/mdn417 10.1200/JCO.2007.12.4784 10.1093/annonc/mdw422 10.1016/S1470-2045(06)70910-X 10.1186/s41687-017-0012-7 10.1016/S0895-4356(99)00206-1 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2021 BioMed Central Ltd. 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. 2021. The Author(s). The Author(s) 2021 |
Copyright_xml | – notice: COPYRIGHT 2021 BioMed Central Ltd. – notice: 2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: 2021. The Author(s). – notice: The Author(s) 2021 |
DBID | AAYXX CITATION ISR 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
DOI | 10.1186/s12885-021-08610-0 |
DatabaseName | CrossRef Gale In Context: Science ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Open Access Full Text |
DatabaseTitle | CrossRef Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Publicly Available Content Database |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2407 |
EndPage | 11 |
ExternalDocumentID | oai_doaj_org_article_93d06c121cdc4e3bb42736a9e54625fd PMC8314582 A672348699 10_1186_s12885_021_08610_0 |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- 0R~ 23N 2WC 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL AAYXX ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CITATION CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB PMFND 3V. 7TO 7XB 8FK AZQEC DWQXO H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 5PM PUEGO |
ID | FETCH-LOGICAL-c605t-6aface0fe8472b60637fbbec243f852a0aae8e04cbbf3a3d77e668ae213882a43 |
IEDL.DBID | 7X7 |
ISSN | 1471-2407 |
IngestDate | Wed Aug 27 01:14:45 EDT 2025 Thu Aug 21 18:35:55 EDT 2025 Fri Jul 11 00:35:16 EDT 2025 Fri Jul 25 23:01:11 EDT 2025 Tue Jun 17 21:29:51 EDT 2025 Tue Jun 10 20:35:26 EDT 2025 Fri Jun 27 03:50:01 EDT 2025 Thu May 22 21:21:53 EDT 2025 Tue Jul 01 04:29:07 EDT 2025 Thu Apr 24 22:59:30 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Language | English |
License | Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c605t-6aface0fe8472b60637fbbec243f852a0aae8e04cbbf3a3d77e668ae213882a43 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | https://www.proquest.com/docview/2562576319?pq-origsite=%requestingapplication% |
PMID | 34315423 |
PQID | 2562576319 |
PQPubID | 44074 |
PageCount | 11 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_93d06c121cdc4e3bb42736a9e54625fd pubmedcentral_primary_oai_pubmedcentral_nih_gov_8314582 proquest_miscellaneous_2555967705 proquest_journals_2562576319 gale_infotracmisc_A672348699 gale_infotracacademiconefile_A672348699 gale_incontextgauss_ISR_A672348699 gale_healthsolutions_A672348699 crossref_citationtrail_10_1186_s12885_021_08610_0 crossref_primary_10_1186_s12885_021_08610_0 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2021-07-27 |
PublicationDateYYYYMMDD | 2021-07-27 |
PublicationDate_xml | – month: 07 year: 2021 text: 2021-07-27 day: 27 |
PublicationDecade | 2020 |
PublicationPlace | London |
PublicationPlace_xml | – name: London |
PublicationTitle | BMC cancer |
PublicationYear | 2021 |
Publisher | BioMed Central Ltd BioMed Central BMC |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central – name: BMC |
References | C Kkf (8610_CR12) 2020; 20 8610_CR2 E Basch (8610_CR6) 2010; 362 JL Hay (8610_CR11) 2014; 23 A Werner-Seidler (8610_CR30) 2020; 273 8610_CR7 BB Reeve (8610_CR13) 2014; 106 L CFaDF (8610_CR23) 1981; 18 E Basch (8610_CR4) 2006; 7 E Basch (8610_CR8) 2014; 106 JA Husted (8610_CR27) 2000; 53 JF Hair (8610_CR24) 2018 A Trotti (8610_CR1) 2007; 25 J Yoon (8610_CR17) 2020; 59 JP Woo (8610_CR22) 2012 AC Dueck (8610_CR9) 2015; 1 8610_CR28 T Miyaji (8610_CR10) 2017; 1 T Kawaguchi (8610_CR16) 2017; 2 R Knoerl (8610_CR31) 2017; 25 A Janice (8610_CR26) 2000; 53 NK Aaronson (8610_CR19) 1993; 85 M Di Maio (8610_CR5) 2015; 33 S Rolstad (8610_CR14) 2011; 14 JCBI Nunnally (8610_CR25) 1994 E Basch (8610_CR3) 2009; 20 V Hagelstein (8610_CR15) 2016; 27 L Hu (8610_CR21) 1999; 6 C Wan (8610_CR18) 2008; 19 J Cohen (8610_CR20) 1988 ST Dong (8610_CR29) 2014; 48 |
References_xml | – volume: 106 start-page: dju244 issue: 9 year: 2014 ident: 8610_CR8 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/dju244 – volume: 6 start-page: 1 issue: 1 year: 1999 ident: 8610_CR21 publication-title: Struct Equ Model Multidiscip J doi: 10.1080/10705519909540118 – volume: 23 start-page: 257 issue: 1 year: 2014 ident: 8610_CR11 publication-title: Qual Life Res doi: 10.1007/s11136-013-0470-1 – volume: 106 start-page: dju129 issue: 7 year: 2014 ident: 8610_CR13 publication-title: JNCI doi: 10.1093/jnci/dju129 – volume: 20 start-page: 1905 issue: 12 year: 2009 ident: 8610_CR3 publication-title: Ann Oncol doi: 10.1093/annonc/mdp542 – ident: 8610_CR2 – volume: 33 start-page: 910 issue: 8 year: 2015 ident: 8610_CR5 publication-title: J Clin Oncol doi: 10.1200/JCO.2014.57.9334 – volume: 59 start-page: 1082 issue: 5 year: 2020 ident: 8610_CR17 publication-title: J Pain Symptom Manag doi: 10.1016/j.jpainsymman.2020.01.015 – volume: 1 start-page: 1051 issue: 8 year: 2015 ident: 8610_CR9 publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2015.2639 – volume: 25 start-page: 3437 issue: 11 year: 2017 ident: 8610_CR31 publication-title: Support Care Cancer doi: 10.1007/s00520-017-3764-y – volume-title: Statistical power analysis for the behavioral sciences year: 1988 ident: 8610_CR20 – volume: 48 start-page: 411 issue: 3 year: 2014 ident: 8610_CR29 publication-title: J Pain Symptom Manag doi: 10.1016/j.jpainsymman.2013.10.027 – volume: 362 start-page: 865 issue: 10 year: 2010 ident: 8610_CR6 publication-title: N Engl J Med doi: 10.1056/NEJMp0911494 – volume: 273 start-page: 106 year: 2020 ident: 8610_CR30 publication-title: J Affect Disord doi: 10.1016/j.jad.2020.04.060 – volume: 20 start-page: 1153 issue: 1 year: 2020 ident: 8610_CR12 publication-title: BMC Cancer doi: 10.1186/s12885-020-07631-5 – volume: 14 start-page: 1101 issue: 8 year: 2011 ident: 8610_CR14 publication-title: Value Health doi: 10.1016/j.jval.2011.06.003 – ident: 8610_CR7 – ident: 8610_CR28 – volume: 2 start-page: 2 issue: 1 year: 2017 ident: 8610_CR16 publication-title: J Patient Rep Outcomes doi: 10.1186/s41687-017-0022-5 – volume: 85 start-page: 365 issue: 5 year: 1993 ident: 8610_CR19 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/85.5.365 – volume: 18 start-page: 39 issue: 1 year: 1981 ident: 8610_CR23 publication-title: J Mark Res doi: 10.1177/002224378101800104 – volume-title: Psychometric Theory. year: 1994 ident: 8610_CR25 – volume: 19 start-page: 2053 issue: 12 year: 2008 ident: 8610_CR18 publication-title: Ann Oncol doi: 10.1093/annonc/mdn417 – volume: 25 start-page: 5121 issue: 32 year: 2007 ident: 8610_CR1 publication-title: J Clin Oncol doi: 10.1200/JCO.2007.12.4784 – volume-title: The concept and understanding of structural equation model year: 2012 ident: 8610_CR22 – volume-title: C., Babin, B. J., and Anderson, R. E: multivariate data analysis, 8th edn year: 2018 ident: 8610_CR24 – volume: 27 start-page: 2294 issue: 12 year: 2016 ident: 8610_CR15 publication-title: Ann Oncol doi: 10.1093/annonc/mdw422 – volume: 7 start-page: 903 issue: 11 year: 2006 ident: 8610_CR4 publication-title: The Lancet Oncology doi: 10.1016/S1470-2045(06)70910-X – volume: 1 start-page: 8 issue: 1 year: 2017 ident: 8610_CR10 publication-title: J Patient Rep Outcomes doi: 10.1186/s41687-017-0012-7 – volume: 53 start-page: 459 issue: 3 year: 2000 ident: 8610_CR26 publication-title: J Clin Epidemiol – volume: 53 start-page: 459 issue: 5 year: 2000 ident: 8610_CR27 publication-title: J Clin Epidemiol doi: 10.1016/S0895-4356(99)00206-1 |
SSID | ssj0017808 |
Score | 2.3605647 |
Snippet | Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for... The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events... Abstract Background The psychometric properties of the simplified Chinese version of the Patient-Reported Outcomes version of the Common Terminology Criteria... |
SourceID | doaj pubmedcentral proquest gale crossref |
SourceType | Open Website Open Access Repository Aggregation Database Enrichment Source Index Database |
StartPage | 1 |
SubjectTerms | Cancer Cancer therapies Care and treatment Chinese Evaluation Factor analysis Hospitals Methods Outcome and process assessment (Health Care) Patient-reported outcomes Patients PRO-CTCAE Quality of life Quantitative psychology Questionnaires Reliability Terminology Validity |
SummonAdditionalLinks | – databaseName: DOAJ Open Access Full Text dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3Ni9UwEA-yB_EifuJzV40ieJCyaZMm6XEVl1VYD-rK3kKaD32wtLJ9T_Bf8K92JkkfWwW9eG0mpZ2ZzEdm8gshzxW4Bc6drmwdXCUi81XHbF0p22oEj2m6dL7i9L08ORPvztvzK1d9YU9YhgfOjDvsuGfS1U3tvBOB970AhyttF1oBoXv0aH3B583JVKkfKM30fERGy8MJrLDGk8i4HSix_LtwQwmt_0-b_Huf5BXHc3yL3CwRIz3KX3qbXAvDHXL9tNTE75KfnyGU9hBMUzt4ehku1hl6-wcdI4Xwjk5r7BqPEGtSvC07TIEWNNUqVwxgYNxuQPXCRL_n_bN5LjwEPaW5ZSbtwFMwM4jvbCmEu9Tifc7wwoQDNd0jZ8dvPr0-qcoNC5WDNGZTSRutCywG8FFND7kMV7EHqYL8om4by6wNOjDh-j5yy71SQUptQ1NziMyt4PfJ3jAO4QGhslER5CpFiF54pjvpuA8wRTswEdavSD0z3LgCP463YFyYlIZoabKQDAjJJCEZtiIvd3O-ZfCNv1K_QjnuKBE4Oz0AdTJFncy_1GlFnqAWmHwKdbf8zRGoLRdadt2KPEsUCJ4xYHfOF7udJvP244cF0YtCFEf4S2fLYQfgFeJtLSgPFpSwut1yeFZHU6zLZBrMWsEx1DD8dDeMM7FjbgjjFmkgV5RKsXZF1EKNFwxajgzrrwlhXPMa66kP_wdH98mNJi08VTXqgOxtLrfhEQRym_5xWrO_AOIYR4w priority: 102 providerName: Directory of Open Access Journals – databaseName: Scholars Portal Journals: Open Access dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwELfGkBAviE9RGGAQEg8o4MSu7TwgNBDTQCoPQNHeLMcfW6Uq2ZoWsX-Bv5o7JykEpr3G5yb13fnu7LvfEfJcgVng3OnM5sFlIjKflczmmbJTjeAxRZnqK2af5eFcfDqaHu2Qod1Rv4DthaEd9pOar5avfp6dvwWFf5MUXsvXLeyxGuuM8bBP4uXuFXIVLJPCjgYz8edWQWmmh8KZC-eNjFPC8P9_p_43e_Ivc3Rwk9zo_Ui63zH-FtkJ9W1ybdbflN8hv76Dg-3Bxaa29nQVlosOkPucNpGC00fbBeaSR_BAKfbQDm2gPcZq1t0jwECzWYNAhpb-6E7VhrnwEKSXdok06VyewuaDqM-WghNMLXZ5hh9M6FDtXTI_-PDt_WHW913IHAQ360zaaF1gMYDlKiqIcLiKFfAauBr1tLDM2qADE66qIrfcKxWk1DYUOQd_3Qp-j-zWTR3uEyoLFYHbUoTohWe6lI77AFO0g43D-gnJhwU3rgclx94YS5OCEy1NxyQDTDKJSYZNyMvtnNMOkuNS6nfIxy0lwmmnB83q2PTaaUrumXR5kTvvROBVJcCrk7YMUwHxYYTPfIJSYLra1O2mYPZBmLnQsiwn5FmiQEiNGnN2ju2mbc3Hr19GRC96otjAv3S2L4GAtUIUrhHl3ogSdN6NhwdxNIPKmAJjWTAXOQw_3Q7jTMyjq0OzQRqIIKVSbDohaiTGowUaj9SLk4Q7rnmOt6wPLn_5Q3K9SCqlskLtkd31ahMegeO2rh4nbfwNoslCLA priority: 102 providerName: Scholars Portal |
Title | Validity and reliability of the simplified Chinese patient-reported outcomes version of the common terminology criteria for adverse events |
URI | https://www.proquest.com/docview/2562576319 https://www.proquest.com/docview/2555967705 https://pubmed.ncbi.nlm.nih.gov/PMC8314582 https://doaj.org/article/93d06c121cdc4e3bb42736a9e54625fd |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3di9QwEA96B-KL-Imr5xpF8EHKtU02SZ_kVu44hT1k9WTxJaT5OBeO9tzuCv4L_tXOpNnVKtxLH5pJPzIfmUwmvyHklYRpgTGrMlN4m_GQu6zKTZFJM1EIHlNW8XzF7EycnvMPi8kiBdy6lFa5tYnRULvWYoz8sERPHZShqN5efc-wahTurqYSGjfJPkKXoVTLxW7BVUiVq-1BGSUOO7DFCs8jY1BQ4CbwYDKKmP3_W-Z_syX_mn5O7pI7yW-kRz2j75EbvrlPbs3SzvgD8usLONQOXGpqGkdX_nLZA3D_pG2g4OTRbom54wE8Too1s33nacJUzfp9A2hoN2sYDN_RH30UbdsXbsLv0z5xJsbhKRgbRHk2FJxearCqMzwwokF1D8n5yfHnd6dZqrOQWVjMrDNhgrE-Dx5mqrKGFQ2ToQbeAheDmpQmN8Yrn3Nb14EZ5qT0Qijjy4KBf244e0T2mrbxjwkVpQzAXcF9cNzlqhKWOQ9dlAVDYdyIFNsB1zaBkGMtjEsdFyNK6J5JGpikI5N0PiJvdn2uegiOa6mnyMcdJcJnxxvt6kInbdQVc7mwRVlYZ7lndc3BixOm8hMOUhbgM5-jFOj-LOrOCOgjEF7GlaiqEXkZKRBCo8EcnQuz6Tr9_tN8QPQ6EYUW_tKadOQBxgpRtwaUBwNK0HE7bN6Ko042ptN_NGJEXuyasSfmzTW-3SANrBiFlPlkRORAjAcDNGxplt8izrhiBe6qPrn-5U_J7TKqlMxKeUD21quNfwaO2roeR20ck_3p8dnH-TiGO-A64wqu8-nX314nQ4Q |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZKkYAL4imWFmoQiAOK6sRZ2zkgVB7VLu32AC3am-s4dlmpStrNLqh_gR_Db2TGSRYCUm-9xuMk9jz82Z4HIS8kLAucWxWZ2Nko9ayIMmbiSJqhwuQxSRbiKyYHYnSUfpoOp2vkVxcLg26VnU0MhrqoLJ6RbyeI1EEZ4uzt2XmEVaPwdrUrodGIxZ67-AFbtvrN-APw92WS7H48fD-K2qoCkQXovoiE8cY65h3Y5SQH_M6lz2Ek8M9eDRPDjHHKsdTmueeGF1I6IZRxScwBjZqUw3uvkeuw8DLc7MnpaoMXS8VUF5ijxHYNtl9h_DMeQgq8dO4tfqFGwP8rwb_emX8td7t3yO0Wp9KdRrDukjVX3iM3Ju1N_H3y8ysA-AIgPDVlQefudNYk_L6glacAKmk9Q191DwiXYo1uVzva5nCNmnsKaKiWC5h8V9Pvzald1xcewnTTxlEnnPtTMG6YVdpQANnUYBVpeGHIPlU_IEdXwoGHZL2sSveIUJFID9IkUueLtGAqE5YXDrooC4bJFAMSdxOubZv0HGtvnOqw-VFCN0zSwCQdmKTZgLxe9TlrUn5cSv0O-biixHTd4UE1P9Gt9uuMF0zYOIltYVPH8zwF1ChM5oYpSLWH39xCKdBN7OvK6OgdUBaeKpFlA_I8UGDKjhJ9gk7Msq71-MvnHtGrlshXMEpr2hALmCvM8tWj3OxRgk2x_eZOHHVr02r9RwMH5NmqGXuin17pqiXSwA5VSMmGAyJ7YtyboH5LOfsW8porHuMt7uPLP75Fbo4OJ_t6f3ywt0FuJUG9ZJTITbK-mC_dEwCJi_xp0ExKjq_aFPwGzm59cQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Validity+and+reliability+of+the+simplified+Chinese+patient-reported+outcomes+version+of+the+common+terminology+criteria+for+adverse+events&rft.jtitle=BMC+cancer&rft.au=Shan-Shan%2C+Yang&rft.au=Chen%2C+Lei&rft.au=Liu%2C+Ying&rft.au=Hai-Jun%2C+Lu&rft.date=2021-07-27&rft.pub=BioMed+Central&rft.eissn=1471-2407&rft.volume=21&rft.spage=1&rft_id=info:doi/10.1186%2Fs12885-021-08610-0 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon |